Innovative Network on Tissue Engineering

The INNTERACT project, funded by the European Interreg POCTEFA programme, is being launched with a clear objective: to improve the transfer of biomedical innovation from the research environment to industry, especially in the fields of tissue engineering and regenerative medicine.

The POCTEFA territory has a high-level scientific and clinical ecosystem, but it is often fragmented and disconnected, which limits its ability to generate economic and social impact. INNTERACT was created to address this challenge through a cross-border and collaborative approach.

Three innovative medical devices, ready to hit the market

The project, which will run from 2025 to 2028, will validate and mature three innovative medical devices that have emerged from previous research, with the aim of bringing them to market. The work will include analysis of the regional context, preclinical and usability studies, definition of regulatory routes, intellectual property protection and technology transfer strategies.

TISSUENET, the cross-border network in Tissue Engineering and Regenerative Medicine

At the same time, INNTERACT will develop TISSUENET, a network that will connect key players in the biomedical sector on both sides of the border. This cooperation will facilitate new collaborations, researcher mobility and greater coordination between technology centres, scientific groups, hospitals, SMEs and business entities.

A leading consortium with nine entities

The project is made up of ten partners from Spain and France, representing the entire biomedical value chain, technology centres, universities, hospitals, SMEs, associations and chambers of commerce: Leartiker (project coordinator), BHC – Basque Health Cluster, Biogipuzkoa, University of Navarra (UNAV), DIVA Expertise, CCI BAYONNE PAYS BASQUE, Centre Hospitalier Universitaire de Toulouse (CHUT), BioTis – Inserm U1026, Cosmetic Valley and Centre Hospitalier Universitaire Montpellier (CHU Montpellier).

Expected impact

INNTERACT will contribute to:

• Generating medical devices ready for transfer to the industrial sector.
• Strengthening cross-border cooperation in health innovation.
• Consolidating a more connected and competitive ecosystem.
• Promoting new opportunities for collaboration between agents in the territory.
• Generating benefits for patients, companies and clinical centres in the POCTEFA region.

With this initiative, INNTERACT is positioning itself as a strategic project to accelerate biomedical innovation and promote competitiveness in advanced technologies within the cross-border space.

___________

The INNTERACT project has been 65% co-financed by the European Union through the Interreg VI-A Spain-France-Andorra Programme (POCTEFA 2021-2027). The aim of POCTEFA is to strengthen the economic and social integration of the Spain-France-Andorra border area.